Impact of special patient populations on the pharmacokinetics of echinocandins
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of special patient populations on the pharmacokinetics of echinocandins
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 13, Issue 6, Pages 799-815
Publisher
Informa UK Limited
Online
2015-05-07
DOI
10.1586/14787210.2015.1028366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Disposition in Obesity: Toward Evidence-Based Dosing
- (2015) Catherijne A.J. Knibbe et al. Annual Review of Pharmacology and Toxicology
- Pharmacokinetic and Safety Profiles of Repeated-dose Prophylactic Micafungin in Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation
- (2015) Edythe Albano et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos
- (2015) JP Pasipanodya et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis
- (2014) Ping Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
- (2014) Chris Stockmann et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications
- (2014) Julie Autmizguine et al. DRUGS
- Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects
- (2014) Nasrullah A. Undre et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration
- (2014) Emilio Maseda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration
- (2014) Gerardo Aguilar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of caspofungin in ICU patients
- (2014) E. W. Muilwijk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
- (2014) Andreas H Groll et al. LANCET ONCOLOGY
- Epidemiology and risk factors for invasive candidiasis
- (2014) Nur Yapar Therapeutics and Clinical Risk Management
- Favorable Outcome of Neonatal Cerebrospinal Fluid Shunt-Associated Candida Meningitis with Caspofungin
- (2013) Jop Jans et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis
- (2013) Gudrun Würthwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low but Sufficient Anidulafungin Exposure in Critically Ill Patients
- (2013) Marjolijn J. P. van Wanrooy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths
- (2013) Ronald G. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy
- (2013) Stefan Weiler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
- (2013) Ping Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
- (2013) Rick Admiraal et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations
- (2013) Ibrahim Ince et al. CLINICAL PHARMACOKINETICS
- Neonatal sepsis: Progress towards improved outcomes
- (2013) Andi L. Shane et al. JOURNAL OF INFECTION
- Safety and Pharmacokinetic Profiles of Repeated-dose Micafungin in Children and Adolescents Treated for Invasive Candidiasis
- (2013) Daniel K. Benjamin et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation
- (2013) K. Oshima et al. Transplant Infectious Disease
- Pharmacokinetics of Caspofungin in Two Patients with Burn Injuries
- (2012) V. Jullien et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic-Pharmacodynamic Analysis of Anidulafungin in Adult Patients with Fungal Infections
- (2012) Ping Liu ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *Information in this manuscript was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
- (2012) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
- (2012) Margreke J.E. Brill et al. CLINICAL PHARMACOKINETICS
- Improving antibiotic dosing in special situations in the ICU
- (2012) Janattul-Ain Jamal et al. Current Opinion in Critical Care
- Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation
- (2012) Yasuyuki Inoue et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics of Micafungin in Pediatric Patients With Invasive Candidiasis and Candidemia
- (2012) Nasrullah A. Undre et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Impact of a Transjugular Intrahepatic Portosystemic Shunt on the Pharmacokinetics of Caspofungin in a Critically Ill Patient
- (2012) Isabel Spriet et al. PHARMACOLOGY
- Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction
- (2012) K.C.M. van der Elst et al. Transplant Infectious Disease
- Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients
- (2011) Chi-Chung Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients
- (2011) Gudrun Würthwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People
- (2011) Ronald G. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Micafungin Concentrations in the Plasma and Burn Eschar of Severely Burned Patients
- (2011) Junichi Sasaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia
- (2011) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding
- (2011) Souzan B. Yanni et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates
- (2011) M Cohen-Wolkowiez et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Implications of Obesity for Drug Therapy: Limitations and Challenges
- (2011) R Jain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis
- (2011) Isabel Spriet et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Micafungin therapy in a critically ill, morbidly obese patient
- (2011) A. Zomp et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration
- (2011) J. M. Leitner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modeling and predicting drug pharmacokinetics in patients with renal impairment
- (2011) Karen Rowland Yeo et al. Expert Review of Clinical Pharmacology
- Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
- (2010) A. H. Groll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
- (2010) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
- (2010) Marta Ulldemolins et al. CLINICAL PHARMACOKINETICS
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants
- (2010) Elizabeth M. Migoya et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin
- (2010) Gopal Krishna et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Micafungin Does Not Influence the Concentration of Tacrolimus in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) N. Fukuoka et al. TRANSPLANTATION PROCEEDINGS
- The Impact of Total Bilirubin on Plasma Micafungin Levels in Living-Donor Liver Transplantation Recipients with Severe Liver Dysfunction
- (2009) Yuichi Muraki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
- (2009) Robert F. Betts et al. CLINICAL INFECTIOUS DISEASES
- Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
- (2009) D K Benjamin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Extended daily dialysis does not affect the pharmacokinetics of anidulafungin
- (2009) Olaf Burkhardt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation
- (2009) I. Spriet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PHARMACOKINETICS OF PROPHYLACTIC MICAFUNGIN IN VERY-LOW-BIRTH-WEIGHT INFANTS
- (2009) Mayumi Kawada et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
- (2009) P Brian Smith et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers
- (2008) M. Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age
- (2008) X. Saez-Llorens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Burns on Pharmacokinetics and Pharmacodynamics of Drugs Used in the Care of Burn Patients
- (2008) Benoit Blanchet et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
- (2008) Roger K. Verbeeck EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation
- (2008) Stéphanie Ruiz et al. INTENSIVE CARE MEDICINE
- Caspofungin as First-Line Therapy for the Treatment of Invasive Aspergillosis After Thoracic Organ Transplantation
- (2008) Jan Groetzner et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Population pharmacokinetics of micafungin in adult patients
- (2007) Tawanda Gumbo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates
- (2007) William W. Hope et al. JOURNAL OF INFECTIOUS DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now